$0.3601
At close: Dec 30, 7:59 PM EDT
$0.3627
0.002600.72%
After Hours: 7:59 PM EDT
Comments
Loading...
Tonix Pharmaceuticals (TNXP) Forecast
NewsEarningsTonix Pharmaceuticals (TNXP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News Summary
Tonix Pharmaceuticals Stock (NASDAQ: TNXP) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Tonix Pharmaceuticals (TNXP) stock?
You can purchase shares of Tonix Pharmaceuticals (NASDAQ:TNXP) through any online brokerage.
Who are Tonix Pharmaceuticals (TNXP) competitors?
Other companies in Tonix Pharmaceuticals’s space includes: Fortress Biotech (NASDAQ:FBIO), Connect Biopharma Hldgs (NASDAQ:CNTB), FibroGen (NASDAQ:FGEN), Inovio Pharmaceuticals (NASDAQ:INO) and Elicio Therapeutics (NASDAQ:ELTX).
What is the forecast, or price target, for Tonix Pharmaceuticals (TNXP) stock?
Tonix Pharmaceuticals has a consensus price target of $4.87.
What is the current price for Tonix Pharmaceuticals (TNXP)?
The stock price for Tonix Pharmaceuticals (NASDAQ: TNXP) is $0.3627 last updated December 30, 2024 at 7:59 PM EST.
Does Tonix Pharmaceuticals (TNXP) pay a dividend?
There are no upcoming dividends for Tonix Pharmaceuticals.
When is Tonix Pharmaceuticals (NASDAQ:TNXP) reporting earnings?
Tonix Pharmaceuticals’s Q4 earnings are confirmed for Monday, March 31, 2025.
Is Tonix Pharmaceuticals (TNXP) going to split?
There is no upcoming split for Tonix Pharmaceuticals.
What sector and industry does Tonix Pharmaceuticals (TNXP) operate in?
Tonix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.